Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to systematically describe the clinical characteristics and outcomes of patients with pituitary complex and rare diseases at Peking Union Medical College Hospital. The main questions it aims to answer are: - What are the influencing factors and rates of remission? - What are the comorbidities associated with these diseases? - What are the perioperative events, radiological findings, and pathological features? Researchers will compare different patient groups to see if there are significant differences in these outcomes. Participants will: - Undergo detailed clinical evaluations. - Provide medical history and data for analysis. - Participate in follow-up assessments to monitor disease progression and treatment outcomes.


Clinical Trial Description

The study aims to provide a comprehensive analysis of pituitary complex and rare diseases at Peking Union Medical College Hospital. By leveraging a large cohort, the research will explore various clinical characteristics and outcomes. Specifically, the study will examine influencing factors and rates of remission, the presence of comorbidities, and perioperative events. Additionally, it will evaluate radiological findings and pathological features to better understand these conditions. Through this detailed investigation, the study seeks to enhance knowledge and inform clinical practice regarding the management and prognosis of pituitary complex and rare diseases. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06435195
Study type Observational
Source Peking Union Medical College Hospital
Contact Yong Yao, MD
Phone +8669152530
Email yaoyong@pumch.cn
Status Recruiting
Phase
Start date January 1, 2024
Completion date December 2026

See also
  Status Clinical Trial Phase
Recruiting NCT04897802 - Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) Phase 4
Completed NCT03137615 - The Cardiovascular Changes Associated With Septal Local Anaesthesia N/A
Completed NCT03305016 - A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency Phase 3
Completed NCT02084134 - Peri-Operative Steroid Management in Patients N/A
Completed NCT00234533 - Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq Phase 3
Completed NCT04902235 - Identification and Clinical Relevance of an Oxytocin Deficient State (CRH Study) Phase 4
Recruiting NCT04951557 - Setting Benchmarks for Transsphenoidal Resection of Pituitary Adenomas
Active, not recruiting NCT00473369 - Prognosis of Atypical Pituitary Adenomas N/A
Active, not recruiting NCT03665064 - Long Term Outcome Study in Patients With Pituitary Disorders
Completed NCT02782208 - Lipolytic Effects of GH in Hypopituitary Patients in Vivo N/A
Recruiting NCT04326374 - Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Chinese Pediatric Growth Hormone Deficiency Phase 3
Completed NCT03344458 - A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial Phase 3
Completed NCT02781727 - A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD) Phase 3